ERBB2 and gastric cancer: Among those, four cell lines (NCI-N87, KE39, NUGC-4, and MKN-7) were ERBB2-amplified cell lines that showed lower IC50 (μM) to drug Lapatinib than other GC cell lines (P = 0.031, Figure 4A, left).